TWI867191B - 含戊酸倍他米松(betamethasone valerate)之醫藥組成物 - Google Patents

含戊酸倍他米松(betamethasone valerate)之醫藥組成物 Download PDF

Info

Publication number
TWI867191B
TWI867191B TW110109848A TW110109848A TWI867191B TW I867191 B TWI867191 B TW I867191B TW 110109848 A TW110109848 A TW 110109848A TW 110109848 A TW110109848 A TW 110109848A TW I867191 B TWI867191 B TW I867191B
Authority
TW
Taiwan
Prior art keywords
pharmaceutical composition
component
stability
aforementioned
betamethasone valerate
Prior art date
Application number
TW110109848A
Other languages
English (en)
Chinese (zh)
Other versions
TW202200154A (zh
Inventor
村里博志
友田宜孝
純浦文枝
岩田洋一
Original Assignee
日商塩野義醫藥保健股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商塩野義醫藥保健股份有限公司 filed Critical 日商塩野義醫藥保健股份有限公司
Publication of TW202200154A publication Critical patent/TW202200154A/zh
Application granted granted Critical
Publication of TWI867191B publication Critical patent/TWI867191B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TW110109848A 2020-03-18 2021-03-18 含戊酸倍他米松(betamethasone valerate)之醫藥組成物 TWI867191B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020047638 2020-03-18
JP2020-047638 2020-03-18

Publications (2)

Publication Number Publication Date
TW202200154A TW202200154A (zh) 2022-01-01
TWI867191B true TWI867191B (zh) 2024-12-21

Family

ID=77772186

Family Applications (1)

Application Number Title Priority Date Filing Date
TW110109848A TWI867191B (zh) 2020-03-18 2021-03-18 含戊酸倍他米松(betamethasone valerate)之醫藥組成物

Country Status (3)

Country Link
JP (1) JP7346712B2 (https=)
TW (1) TWI867191B (https=)
WO (1) WO2021187592A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023007359A (ja) * 2021-06-29 2023-01-18 ロート製薬株式会社 皮膚外用医薬組成物

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005343834A (ja) * 2004-06-03 2005-12-15 Rohto Pharmaceut Co Ltd 皮膚外用剤
JP2006036675A (ja) * 2004-07-26 2006-02-09 Zeria Pharmaceut Co Ltd 外用剤
US20140187518A1 (en) * 2012-12-28 2014-07-03 Rak Holdings Llc Anti-itch scalp treatment compositions and combinations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3434911B2 (ja) * 1994-09-29 2003-08-11 日清ファルマ株式会社 皮膚外用剤
JP4824336B2 (ja) * 2004-05-07 2011-11-30 ロート製薬株式会社 皮膚外用剤
JP4824337B2 (ja) * 2004-05-07 2011-11-30 ロート製薬株式会社 皮膚外用剤

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005343834A (ja) * 2004-06-03 2005-12-15 Rohto Pharmaceut Co Ltd 皮膚外用剤
JP2006036675A (ja) * 2004-07-26 2006-02-09 Zeria Pharmaceut Co Ltd 外用剤
US20140187518A1 (en) * 2012-12-28 2014-07-03 Rak Holdings Llc Anti-itch scalp treatment compositions and combinations

Also Published As

Publication number Publication date
JPWO2021187592A1 (https=) 2021-09-23
JP7346712B2 (ja) 2023-09-19
TW202200154A (zh) 2022-01-01
WO2021187592A1 (ja) 2021-09-23

Similar Documents

Publication Publication Date Title
RU2245715C2 (ru) Композиция лака для ногтей
JP5631932B2 (ja) 半固形製剤中でのオクテニジン二塩酸塩の使用
ES3016559T3 (en) Urolithin a and a composition containing same for external use in inflammations of various etiologies
WO2020172266A1 (en) Topical rapamycin formulations and their use in treating facial angiofibromas and other skin disorders
EUR An unusual complication of late onset allergic contact dermatitis to povidone iodine in Oral & Maxillofacial Surgery: A report of 2 cases
EP2663299A1 (en) Melatonin and an antimicrobial or antibacterial agent for the treatment of acne
TWI867191B (zh) 含戊酸倍他米松(betamethasone valerate)之醫藥組成物
WO2012130609A1 (en) New combination comprising n-acetyl-l-cysteine and its use
EP1575598B1 (en) Pharmaceutical compositions comprising a combination of calcitriol and clobetasol propionate
Pukale et al. Synthesis, characterization and topical application of novel bifunctional peptide metallodendrimer
ZA200505174B (en) Pharmaceutical compositions comprising a combination of calcitriol and a clobetasol propionate
US20090297616A1 (en) Wound Care Composition
TWI885097B (zh) 含戊酸倍他米松(betamethasone valerate)之組成物
AU2003242647B2 (en) Use of amide derivative of GE 2270 factor A3 for the treatment of acne
CN112236163B (zh) 使用协同量的硼酸增强缩酚酸肽抗生素的抗菌作用
JP2023044681A (ja) ベタメタゾン吉草酸エステル含有軟膏剤
JP7309215B2 (ja) 皮膚外用剤
US20250144008A1 (en) Compositions and methods for treating skin disorders
Sterczala et al. The effect of dental gel formulation on human primary fibroblasts—An in vitro study
WO2022163686A1 (ja) ベタメタゾン吉草酸エステル含有軟膏剤組成物
JP2023044682A (ja) ベタメタゾン吉草酸エステル含有クリーム剤
EP1854466A1 (en) Pharmaceutical composition comprising a combination of calcitriol and clobetasol propionate
WO2023215844A1 (en) Propionic acid ester compositions useful for treating eczema
US20250352515A1 (en) Topical formulations
AU2014100280B4 (en) A method of treating skin lesions